185 related articles for article (PubMed ID: 25533001)
1. Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.
Umunnakwe CN; Loyd H; Cornick K; Chavez JR; Dobbs D; Carpenter S
Retrovirology; 2014 Dec; 11():115. PubMed ID: 25533001
[TBL] [Abstract][Full Text] [Related]
2. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
[TBL] [Abstract][Full Text] [Related]
3. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
Chung H ; Derse D
J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
[TBL] [Abstract][Full Text] [Related]
4. Structural model of the Rev regulatory protein from equine infectious anemia virus.
Ihm Y; Sparks WO; Lee JH; Cao H; Carpenter S; Wang CZ; Ho KM; Dobbs D
PLoS One; 2009; 4(1):e4178. PubMed ID: 19137065
[TBL] [Abstract][Full Text] [Related]
5. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.
Zhang X; Li J; Zhang M; Bai B; Ma W; Lin Y; Guo X; Wang XF; Wang X
J Virol; 2022 Sep; 96(18):e0098622. PubMed ID: 36069548
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
7. Arginine side-chain dynamics in the HIV-1 rev-RRE complex.
Wilkinson TA; Botuyan MV; Kaplan BE; Rossi JJ; Chen Y
J Mol Biol; 2000 Nov; 303(4):515-29. PubMed ID: 11054288
[TBL] [Abstract][Full Text] [Related]
8. Identification of a homogenous structural basis for oligomerization by retroviral Rev-like proteins.
Umunnakwe CN; Dorman KS; Dobbs D; Carpenter S
Retrovirology; 2017 Aug; 14(1):40. PubMed ID: 28830558
[TBL] [Abstract][Full Text] [Related]
9. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation.
Nam YS; Petrovic A; Jeong KS; Venkatesan S
J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.
Lee JH; Culver G; Carpenter S; Dobbs D
PLoS One; 2008 Jun; 3(6):e2272. PubMed ID: 18523581
[TBL] [Abstract][Full Text] [Related]
11. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal splice sites of equine infectious anaemia virus control Rev responsiveness.
Rosin-Arbesfeld R; Yaniv A; Gazit A
J Gen Virol; 2000 May; 81(Pt 5):1265-72. PubMed ID: 10769069
[TBL] [Abstract][Full Text] [Related]
13. Temperature inducible beta-sheet structure in the transactivation domains of retroviral regulatory proteins of the Rev family.
Thumb W; Graf C; Parslow T; Schneider R; Auer M
Spectrochim Acta A Mol Biomol Spectrosc; 1999 Nov; 55A(13):2729-43. PubMed ID: 10629982
[TBL] [Abstract][Full Text] [Related]
14. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
Martarano L; Stephens R; Rice N; Derse D
J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
[TBL] [Abstract][Full Text] [Related]
15. Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
Jin J; Sturgeon T; Chen C; Watkins SC; Weisz OA; Montelaro RC
J Virol; 2007 Oct; 81(20):11226-35. PubMed ID: 17686839
[TBL] [Abstract][Full Text] [Related]
16. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
[TBL] [Abstract][Full Text] [Related]
17. Molecular and biological characterization of equine infectious anemia virus Rev.
Carpenter S; Dobbs D
Curr HIV Res; 2010 Jan; 8(1):87-93. PubMed ID: 20210784
[TBL] [Abstract][Full Text] [Related]
18. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
Booth DS; Cheng Y; Frankel AD
Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
[TBL] [Abstract][Full Text] [Related]
19. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
